Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU Program
- Status
- COMPLETED
- Phase
- N/A
Safety, Efficacy and Pharmacokinetic of BPI-9016M in Patients With c-Met- Dysregulated Advanced NSCLC
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Paclitaxel, Carboplatin, and PF-05212384 in Advanced or Metastatic NSCLC (UF-STO-LUNG-002)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety, Tolerability and Pharmacokinetic Profile of BPI-15086 in EGFR T790M Mutation-positive NSCLC Patients
- Status
- COMPLETED
- Phase
- PHASE1
Suction on Post-Operative Chest Tubes
- Status
- COMPLETED
- Phase
- NA
Real-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
- Status
- COMPLETED
- Phase
- N/A
Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase 1/2 Study of Ensartinib and Durvalumab, in ALK-rearranged Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
First-in-human Phase I Study of a Selective c-Met Inhibitor PLB1001
- Status
- COMPLETED
- Phase
- PHASE1
Yoga in Improving Quality of Life in Patients With Non-small Cell Lung Cancer Undergoing Treatment
- Status
- TERMINATED
- Phase
- NA
An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation
- Status
- UNKNOWN
- Phase
- PHASE3
Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
International Lung Screen Trial (ILST)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1